Complete the pre-quiz poll to access the course episodes.
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships with ineligible companies. Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty
have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.
| Faculty | Relationship Identified With: |
| Iacopo Olivotto, MD (Course Chair)
| Consultant/Advisor: Amicus Therapeutics, Inc; Bristol Myers Squibb; Cytokinetics; Genzyme Corporation; Rocket Pharmaceuticals, Inc.; Takeda Pharmaceuticals; Tenaya Therapeutics |
| Christoph Maack, MD
| Consultant/Advisor: AstraZeneca; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Eli Lilly and Company; Novo Nordisk A/S Speaker’s Bureau: AstraZeneca; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Diaplan; Eli Lilly and Company; Novo Nordisk A/S |
| Michelle Michels, MD | Consultant/Advisor: Alnylam Pharmaceuticals, Inc.; AstraZeneca; Bayer AG; Cytokinetics; Imbria; Sanofi Grant/Research Support: Bristol Myers Squibb; Cytokinetics Speaker’s Bureau: Pfizer Inc. |
| Gianluigi Savarese, MD | Consultant/Advisor: Abbott; Edwards Lifesciences Corporation; F. Hoffmann-La Roche Ltd.; Getz Pharma; Hikma Pharmaceuticals; Intas Pharmaceuticals Ltd.; Teva Pharmaceutical Industries Ltd.; The Menarini Group Grant/Research Support: AstraZeneca; Bayer AG; Boehringer Ingelheim International GmbH; Boston Scientific; CSL Vifor; Cytokinetics; Pharmacosmos A/S; Medtronic; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Servier Pharmaceuticals |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC, Nicole McMenamin and Chelsey Simonds hereby state that they do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Through an agreement between the American Medical Association and the Union Européenne des Médecins Spécialistes, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®). These credits will be recognized by all National Accreditation Authorities in Europe with which the UEMS has a signed agreement of recognition of credits.
This activity has been supported by an independent educational grant from Bristol Myers Squibb.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Bristol Myers Squibb do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
For all CE inquiries or special needs, please contact admin@academiccme.com.
811 S. Orleans Ave. Tampa, Fl 33606
